FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE

MDR report key: 3212461 · Received July 9, 2013

Report

Report Number
2124215-2013-09340
Event Type
Injury
Date Received
July 9, 2013
Date of Event
May 29, 2013
Report Date
October 2, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
LWS
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

UPON ADDITIONAL INFORMATION, THIS INVESTIGATION WILL BE UPDATED.

Additional Manufacturer Narrative · 1

IT WAS NOTED THAT THE LEAD WAS EXPLANTED. IT IS NOT KNOW IF THE LEAD WILL BE RETURNED FOR ANALYSIS. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE THIS INVESTIGATION WILL BE UPDATED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT NOISE, OVERSENSING RESULTING IN ANTI TACHYCARDIA THERAPY WAS DELIVERED TO THE PATIENT. FURTHER REVIEW OF DAILY MEASUREMENTS NOTED THAT SOME VALUES WERE LOW OUT OF RANGE, AND A RIGHT VENTRICULAR LEAD INSULATION ISSUE WAS SUSPECTED. THE PATIENT WAS HOSPITALIZED AND ANOTHER PROCEDURE TO IMPLANT A NEW LEAD WILL BE SCHEDULED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
311902 ENDOTAK RELIANCE IMPLANTABLE LEAD LWS CPI - DEL CARIBE 0175

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| L| R